Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Merck
Fish and Richardson
Chubb
Dow
Novartis
Teva
Mallinckrodt
Harvard Business School
Medtronic

Generated: October 19, 2017

DrugPatentWatch Database Preview

Alkem Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM LABS LTD, and what generic and branded alternatives to ALKEM LABS LTD drugs are available?

ALKEM LABS LTD has twenty-six approved drugs.

There are seven tentative approvals on ALKEM LABS LTD drugs.

Summary for Applicant: Alkem Labs Ltd

US Patents:0
Tradenames:23
Ingredients:23
NDAs:26
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd
CEPHALEXIN
cephalexin
CAPSULE;ORAL090836-004Mar 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
AMLODIPINE AND OLMESARTAN MEDOXOMIL
amlodipine besylate; olmesartan medoxomil
TABLET;ORAL209042-003Aug 14, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
CEPHALEXIN
cephalexin
CAPSULE;ORAL090836-003Mar 29, 2013RXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
NEBIVOLOL HYDROCHLORIDE
nebivolol hydrochloride
TABLET;ORAL203741-002Jun 24, 2015DISCNNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
FINASTERIDE
finasteride
TABLET;ORAL204304-001Jan 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
ROSUVASTATIN CALCIUM
rosuvastatin calcium
TABLET;ORAL206465-004Mar 21, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
QUETIAPINE FUMARATE
quetiapine fumarate
TABLET;ORAL201504-006Feb 12, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL204453-004Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
OLANZAPINE
olanzapine
TABLET;ORAL202295-002Oct 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
OLANZAPINE
olanzapine
TABLET;ORAL202295-003Oct 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chubb
Queensland Health
US Army
Novartis
Medtronic
Baxter
Accenture
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot